These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30063703)

  • 1. An attenuated replication-competent chikungunya virus with a fluorescently tagged envelope.
    Jin J; Sherman MB; Chafets D; Dinglasan N; Lu K; Lee TH; Carlson LA; Muench MO; Simmons G
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006693. PubMed ID: 30063703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of vesicular stomatitis virus pseudotype with Chikungunya virus envelope protein.
    Tong W; Yin XX; Lee BJ; Li YG
    Acta Virol; 2015 Jun; 59(2):189-93. PubMed ID: 26104337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visualization of chikungunya virus infection
    Zhang HL; Dong HL; Zhang YN; Xu LL; Deng CL; Li XF; Li XD; Ye HQ; Yuan ZM; Qin CF; Zhang B
    Emerg Microbes Infect; 2019; 8(1):1574-1583. PubMed ID: 31682177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Chikungunya Virus Variants at the E1-E1 Interglycoprotein Spike Interface Impact Virus Attachment and Inflammation.
    Rangel MV; McAllister N; Dancel-Manning K; Noval MG; Silva LA; Stapleford KA
    J Virol; 2022 Feb; 96(4):e0158621. PubMed ID: 34935436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Conserved Phenylalanine Residues in the E1 Fusion Loop of Alphaviruses Are Essential for Viral Infectivity.
    Lucas CJ; Davenport BJ; Carpentier KS; Tinega AN; Morrison TE
    J Virol; 2022 May; 96(9):e0006422. PubMed ID: 35416719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host oxidative folding pathways offer novel anti-chikungunya virus drug targets with broad spectrum potential.
    Langsjoen RM; Auguste AJ; Rossi SL; Roundy CM; Penate HN; Kastis M; Schnizlein MK; Le KC; Haller SL; Chen R; Watowich SJ; Weaver SC
    Antiviral Res; 2017 Jul; 143():246-251. PubMed ID: 28461071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A chikungunya fever vaccine utilizing an insect-specific virus platform.
    Erasmus JH; Auguste AJ; Kaelber JT; Luo H; Rossi SL; Fenton K; Leal G; Kim DY; Chiu W; Wang T; Frolov I; Nasar F; Weaver SC
    Nat Med; 2017 Feb; 23(2):192-199. PubMed ID: 27991917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Functional Determinants in the Chikungunya Virus E2 Protein.
    Weber C; Berberich E; von Rhein C; Henß L; Hildt E; Schnierle BS
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005318. PubMed ID: 28114368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of green fluorescent protein-tagged virus-like particles as a tracer in the early phase of chikungunya infection.
    Tumkosit U; Maeda Y; Kishishita N; Siripanyaphinyo U; Omori H; Chetanachan P; Sittisaman P; Jityam C; Priengprom T; Mizushima H; Wongjaroen P; Mekada E; Tatsumi M; Takeda N; Tanaka A
    Virus Res; 2019 Oct; 272():197732. PubMed ID: 31445103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the Role of E2 Protein Domains in Alphavirus Pathogenicity.
    Weger-Lucarelli J; Aliota MT; Wlodarchak N; Kamlangdee A; Swanson R; Osorio JE
    J Virol; 2015 Dec; 90(5):2418-33. PubMed ID: 26676771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
    Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
    mBio; 2016 May; 7(3):. PubMed ID: 27222471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.
    Silva LA; Khomandiak S; Ashbrook AW; Weller R; Heise MT; Morrison TE; Dermody TS
    J Virol; 2014 Mar; 88(5):2385-97. PubMed ID: 24371059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of an infectious Chikungunya virus cDNA clone and stable insertion of mCherry reporter genes at two different sites.
    Kümmerer BM; Grywna K; Gläsker S; Wieseler J; Drosten C
    J Gen Virol; 2012 Sep; 93(Pt 9):1991-1995. PubMed ID: 22673932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of the Opal Stop Codon Attenuates Chikungunya Virus-Induced Arthritis and Pathology.
    Jones JE; Long KM; Whitmore AC; Sanders W; Thurlow LR; Brown JA; Morrison CR; Vincent H; Peck KM; Browning C; Moorman N; Lim JK; Heise MT
    mBio; 2017 Nov; 8(6):. PubMed ID: 29138302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the chikungunya virus E1 glycoprotein domain II and hinge influence E2 conformation, infectivity, and virus-receptor interactions.
    Thannickal SA; Battini L; Spector SN; Noval MG; Álvarez DE; Stapleford KA
    J Virol; 2024 Jul; 98(7):e0067924. PubMed ID: 38842335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residue 82 of the Chikungunya virus E2 attachment protein modulates viral dissemination and arthritis in mice.
    Ashbrook AW; Burrack KS; Silva LA; Montgomery SA; Heise MT; Morrison TE; Dermody TS
    J Virol; 2014 Nov; 88(21):12180-92. PubMed ID: 25142598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.
    Lam S; Nyo M; Phuektes P; Yew CW; Tan YJ; Chu JJ
    MAbs; 2015; 7(6):1178-94. PubMed ID: 26305993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Events in Chikungunya Virus Infection-From Virus Cell Binding to Membrane Fusion.
    van Duijl-Richter MK; Hoornweg TE; Rodenhuis-Zybert IA; Smit JM
    Viruses; 2015 Jul; 7(7):3647-74. PubMed ID: 26198242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response.
    Her Z; Teng TS; Tan JJ; Teo TH; Kam YW; Lum FM; Lee WW; Gabriel C; Melchiotti R; Andiappan AK; Lulla V; Lulla A; Win MK; Chow A; Biswas SK; Leo YS; Lecuit M; Merits A; Rénia L; Ng LF
    EMBO Mol Med; 2015 Jan; 7(1):24-41. PubMed ID: 25452586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry.
    Henß L; Beck S; Weidner T; Biedenkopf N; Sliva K; Weber C; Becker S; Schnierle BS
    Virol J; 2016 Aug; 13(1):149. PubMed ID: 27581733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.